CTLT announces an agreement to sell its oral solids development and manufacturing facility in Somerset to Ardena.

Shares of Catalent, Inc. (NYSE:CTLT – Get Free Report) have received an average recommendation of “Hold” from the eight ratings firms that are covering the company, Marketbeat Ratings reports. Eight ...

On Monday, Catalent Inc (CTLT) stock saw a modest uptick, ending the day at $60.65 which represents a slight increase of $0.20 or 0.33% from the prior close of $60.45. The stock opened at $60.5 and ...

Catalent (CTLT) sells Somerset, NJ facility to Ardena. Corporate headquarters to shift to new location post-transition.

Based on these metrics and many more, TAK holds a Value grade of A, while CTLT has a Value grade of C. Both TAK and CTLT are impressive stocks with solid earnings outlooks, but based on these ...

On Thursday, Catalent Inc (CTLT) stock saw a decline, ending the day at $60.71 which represents a decrease of $-0.25 or -0.41% from the prior close of $60.96. The stock opened at $60.78 and touched a ...

Investors interested in stocks from the Medical - Drugs sector have probably already heard of Takeda Pharmaceutical Co. (TAK) and Catalent (CTLT). But which of these two stocks is more attractive ...

Below is Validea's guru fundamental report for CATALENT INC (CTLT). Of the 22 guru strategies we follow, CTLT rates highest using our Value Investor model based on the published strategy of ...

Catalent, Inc. (CTLT), a provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer ...

Fintel reports that on September 24, 2024, Baird downgraded their outlook for Catalent (NYSE:CTLT) from Outperform to Neutral ...